Cardiovascular complications in COVID-19 patients with or without diabetes mellitus

Temidayo Abe1, Obiora Egbuche2, Joseph Igwe1

  • 1Internal Medicine Residency Program, Morehouse School of Medicine, Atlanta, GA, USA.

Insights

Patients with diabetes mellitus (DM) face significantly higher risks of severe cardiovascular complications from COVID-19. This study highlights increased odds of heart failure and other cardiac events in diabetic individuals infected with the virus.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Endocrinology

Background:

  • Coronavirus disease 2019 (COVID-19) presents a global health crisis.
  • Preliminary data suggest worse outcomes for patients with diabetes mellitus (DM).
  • The specific magnitude of cardiovascular complications in diabetic COVID-19 patients remains unclear.

Purpose of the Study:

  • To elucidate the cardiovascular (CV) complications in diabetic patients with COVID-19.
  • To compare the incidence of specific CV outcomes between diabetic and non-diabetic COVID-19 patients.
  • To determine the adjusted odds of CV events in diabetic COVID-19 patients.

Main Methods:

  • A cohort of 142 patients with laboratory-confirmed COVID-19 was analyzed.
  • 71 patients (50%) had a diagnosis of diabetes mellitus (DM).
  • Multivariate logistic regression was used to compare outcomes, adjusting for age, sex, and glycemic control.

Main Results:

  • Diabetic patients exhibited significantly higher unadjusted rates for composite cardiovascular endpoints (73.2% vs. 40.6%), acute myocarditis (36.6% vs. 15.5%), acute heart failure (25.3% vs. 5.6%), acute myocardial infarction (9.9% vs. 1.4%), and new-onset atrial fibrillation (12.7% vs. 1.4%).
  • After adjusting for confounding variables, DM patients had increased odds of composite cardiovascular endpoint, acute heart failure, and new-onset atrial fibrillation.
  • Mean age of the cohort was 58 years.

Conclusions:

  • Diabetes mellitus is associated with a substantially increased risk of cardiovascular complications following COVID-19 infection.
  • Diabetic patients with COVID-19 are more likely to experience adverse cardiac events, including heart failure and atrial fibrillation.
  • These findings underscore the importance of close cardiovascular monitoring in diabetic individuals diagnosed with COVID-19.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.5K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
148
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
147